Paid Clinical Trials in Macon, GA
As of July 2026, 75 paid clinical trials are recruiting in Macon, Georgia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Macon offers studies at sites including Atrium Health Navicent for conditions such as Atopic Dermatitis, Graves' Disease, Idiopathic Hypersomnia, Narcolepsy Type 1. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Macon
Trials by drug in Macon
Filter results
72 clinical trials
↓ Download CSVLIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
About research studies in Macon
Macon has approximately 75 recruiting research studies across a wide range of therapeutic areas. Georgia is home to Emory University Hospital, Winship Cancer Institute, and Children's Healthcare of Atlanta, with active research in oncology, infectious disease, and cardiovascular health.
Top Research Study Locations in Macon
Researchers run research studies in Macon, GA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Atrium Health Navicent | B Acute Lymphoblastic Leukemia, Adrenal Gland Pheochromocytoma, Anaplastic Kidney Wilms Tumor | 12 |
| Gastroenterology Associates of Central Georgia | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 7 |
| Alkermes Investigational Site | Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia | 4 |
| Central Georgia Cancer Care | Breast Neoplasms, Neoplasm Metastasis, Non-Small Cell Lung Cancer | 3 |
| GSK Investigational Site | HIV Infections, Multiple Myeloma | 3 |
| Sleep Practitioners, LLC | Narcolepsy, Cataplexy, EDS | 3 |
| The Jones Center Clinical Research | Obesity, Overweight, Atherosclerotic Cardiovascular Disease | 3 |
| Atrium Health Navicent The Medical Center | Open tíbia Fracture, Osteomyelitis Tibia, Persistent Atrial Fibrillation | 2 |
| Gastroenterolgy Associates of Central GA | Colitis, Ulcerative, Crohn Disease | 2 |
| Gastroenterology Associates of Central Georgia, LLC | Bowel; Stricture, Esophageal Stricture | 2 |
| Skin Care Physicians Of Georgia | Alopecia Areata, Alopecia, Areata Alopecia | 2 |
| Skin Care Physicians of Georgia - Macon | Pruritus, Atopic Dermatitis | 2 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| Alkermes Investigator Site | Idiopathic Hypersomnia | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Central Georgia Cancer Care - Macon | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Central Georgia Cancer Care PC | Extensive Stage Small-cell Lung Cancer, Small-cell Lung Cancer | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| East Coast Institute For Research LLC | Kidney Disease, Chronic | 1 |
| East Coast Institute for Research | Type 1 Diabetes Mellitus With Hypoglycemia | 1 |
| GA Arrhythmia Cons & Rsch Inst | Heart Failure, Systemic Inflammation | 1 |
| Gastroenterology Associates of Central GA | Crohn Disease | 1 |
| Georgia Memory Net Memory Assessment Clinic - Macon | Alzheimer Disease | 1 |
| Hemlock Ambulatory Surgery Center | Lumbar Spinal Stenosis | 1 |
| Leo Pharma Investigational site | Atopic Dermatitis | 1 |
Active & Upcoming Studies in Macon (2026)
Recruiting trials in Macon grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (17 active studies)
- A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM) · Phase 2 · GlaxoSmithKline
- Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2 · Phase 3 · AstraZeneca
Diabetes & metabolic (6 active studies)
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes · Phase 3 · Eli Lilly and Company
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity · Phase 3 · Amgen
Cardiovascular (5 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
HIV / STI (3 active studies)
- A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · ViiV Healthcare
- A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) · Phase 2, Phase 3 · Merck Sharp & Dohme LLC
Vaccines (1 active study)
Neurology & pain (1 active study)
- Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry · Emory University
Common conditions studied in Macon
- Atopic Dermatitis (3 active studies). Atopic dermatitis studies test IL-13 inhibitors, JAK inhibitors, and next-generation topical therapies for moderate-to-severe eczema.
- Graves' Disease (3 active studies). Recruiting Graves' Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Idiopathic Hypersomnia (3 active studies). Recruiting Idiopathic Hypersomnia studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Narcolepsy Type 1 (3 active studies). Recruiting Narcolepsy Type 1 studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non-Small Cell Lung Cancer (3 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- B Acute Lymphoblastic Leukemia (2 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
Leading research sponsors in Macon
- Children's Oncology Group
- Alkermes, Inc.
- AstraZeneca
- Wake Forest University Health Sciences
- Boehringer Ingelheim
Local regulations and guidelines
Clinical trials in Georgia are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Georgia research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Macon. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Macon
Hipa.ai aggregates every recruiting study in Macon from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Macon?
There are approximately 75 recruiting clinical trials in Macon, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Macon pay participants?
Most recruiting trials in Macon compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Macon?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Macon?
The most common conditions under active study in Macon include Atopic Dermatitis (3), Graves' Disease (3), Idiopathic Hypersomnia (3), Narcolepsy Type 1 (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Macon?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Macon on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Macon?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Macon?
Recruiting research sites in Macon include Atrium Health Navicent, Gastroenterology Associates of Central Georgia, Alkermes Investigational Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Macon right now?
The largest active categories in Macon are Cancer & tumors (17), Diabetes & metabolic (6), Cardiovascular (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.